Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002270 · ClinicalTrials.gov registry record · NA
A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
NCT00002270: Completed NA study, sponsored by University of Miami.
NCT00002270 is a NA study that has completed, run by University of Miami. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002270, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To study the effectiveness of alpha interferon (IFN-A2b) and zidovudine (AZT) in treating progressive multifocal leukoencephalopathy (PML) as a complication of HIV-1 infection.
Interventions
- DRUG Zidovudine
- DRUG Interferon alfa-2b
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002270 record still lists
NCT00002270 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Zidovudine is the first listed.
NCT00002270 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002270 about?
NCT00002270 is a clinical study titled "A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection". To study the effectiveness of alpha interferon (IFN-A2b) and zidovudine (AZT) in treating progressive multifocal leukoencephalopathy (PML) as a complication of HIV-1 infection.
What is the current status of trial NCT00002270?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002270?
The interventions under investigation include: Zidovudine (DRUG), Interferon alfa-2b (DRUG).
Who is sponsoring clinical trial NCT00002270?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.